Estrella Immunopharma
ESLA
ESLA
7 hedge funds and large institutions have $143K invested in Estrella Immunopharma in 2023 Q4 according to their latest regulatory filings, with 6 funds opening new positions, increasing their positions, reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
7
Holders Change
+4
Holders Change %
+133.33%
% of All Funds
0.1%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
6
Increased
–
Reduced
–
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
Top Sellers
| 1 |
OCAM
Owl Creek Asset Management
New York
|
$0 |
| 2 |
Jane Street
New York
|
$0 |
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
1
Geode Capital Management
Boston,
Massachusetts
| $63K | +$63K | +56,215 | New |
|
|
ASM
2
ATW SPAC Management
New York
| $44.4K | +$44.4K | +40,000 | New |
|
|
HHGC
3
Hunting Hill Global Capital
New York
| $23.7K | +$23.7K | +21,358 | New |
|
|
MCP
4
Maso Capital Partners
Hong Kong
| $11K | – | – | – |
|
|
TRCT
5
Tower Research Capital (TRC)
New York
| $702 | +$702 | +632 | New |
|
6
UBS Group
Zurich,
Switzerland
| $336 | +$336 | +303 | New |
|
7
Wells Fargo
San Francisco,
California
| $81 | +$81 | +73 | New |
|
|
OCAM
8
Owl Creek Asset Management
New York
| – | -$2.68M | -255,000 | Closed |
|
|
9
Jane Street
New York
| – | -$192K | -20,505 | Closed |
|